D-Index & Metrics Best Publications
Microbiology
India
2023
Medicine
India
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 89 Citations 28,723 432 World Ranking 433 National Ranking 1
Medicine D-index 97 Citations 36,751 576 World Ranking 5577 National Ranking 3

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in India Leader Award

2023 - Research.com Microbiology in India Leader Award

2022 - Research.com Microbiology in India Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Enzyme

His primary areas of study are Visceral leishmaniasis, Leishmaniasis, Immunology, Leishmania donovani and Miltefosine. His studies in Visceral leishmaniasis integrate themes in fields like Surgery, Internal medicine, Adverse effect, Combination therapy and Intensive care medicine. His work in Internal medicine addresses subjects such as Gastroenterology, which are connected to disciplines such as Chemotherapy, Nephrotoxicity, Oral administration and Indian visceral leishmaniasis.

His Leishmaniasis research is multidisciplinary, incorporating elements of Clinical trial, Pharmacology, Veterinary medicine, Leishmania and Drug resistance. The concepts of his Leishmania donovani study are interwoven with issues in Incidence, Virology, Amastigote, Microbiology and Molecular biology. His research in Miltefosine focuses on subjects like Dermatology, which are connected to Cutaneous leishmaniasis.

His most cited work include:

  • Drug Resistance in Leishmaniasis (1224 citations)
  • Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? (1139 citations)
  • Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda (636 citations)

What are the main themes of his work throughout his whole career to date?

Shyam Sundar mainly investigates Visceral leishmaniasis, Leishmaniasis, Leishmania donovani, Immunology and Internal medicine. His Visceral leishmaniasis research is mostly focused on the topic Miltefosine. His study in Leishmaniasis is interdisciplinary in nature, drawing from both Chemotherapy, Serology, Direct agglutination test, Intensive care medicine and Veterinary medicine.

Shyam Sundar interconnects Molecular biology, Amastigote and Drug resistance, Microbiology in the investigation of issues within Leishmania donovani. His work carried out in the field of Immunology brings together such families of science as Peripheral blood mononuclear cell and Asymptomatic. His research combines Gastroenterology and Internal medicine.

He most often published in these fields:

  • Visceral leishmaniasis (54.77%)
  • Leishmaniasis (33.08%)
  • Leishmania donovani (31.38%)

What were the highlights of his more recent work (between 2017-2021)?

  • Visceral leishmaniasis (54.77%)
  • Leishmania donovani (31.38%)
  • Leishmaniasis (33.08%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Visceral leishmaniasis, Leishmania donovani, Leishmaniasis, Immunology and Leishmania. His study in the field of Miltefosine is also linked to topics like Indian subcontinent. His Leishmania donovani study combines topics in areas such as Immunity, Antigen, Microbiology, Intracellular and Pharmacology.

His Leishmaniasis research integrates issues from Xenodiagnosis, Intensive care medicine, Disease and Virology. The Leishmania study combines topics in areas such as Macrophage and Proteomics, Gene, Genome. His Internal medicine research is multidisciplinary, incorporating perspectives in Serology and Rapid diagnostic test.

Between 2017 and 2021, his most popular works were:

  • Eliminating visceral leishmaniasis in South Asia: the road ahead. (37 citations)
  • Current and emerging medications for the treatment of leishmaniasis (33 citations)
  • Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani. (26 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Drug Resistance in Leishmaniasis

Simon L. Croft;Shyam Sundar;Alan H. Fairlamb.
Clinical Microbiology Reviews (2006)

1942 Citations

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

François Chappuis;François Chappuis;Shyam Sundar;Asrat Hailu;Hashim Ghalib.
Nature Reviews Microbiology (2007)

1881 Citations

Visceral leishmaniasis : current status of control, diagnosis, and treatment, and a proposed research and development agenda

Philippe J Guerin;Philippe J Guerin;Piero Olliaro;Piero Olliaro;Shyam Sundar;Marleen Boelaert.
Lancet Infectious Diseases (2002)

1029 Citations

Oral Miltefosine for Indian Visceral Leishmaniasis

Shyam Sundar;T K Jha;C P Thakur;Juergen Engel.
The New England Journal of Medicine (2002)

851 Citations

Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic

Shyam Sundar;Deepak K. More;Manoj K. Singh;Vijay P. Singh.
Clinical Infectious Diseases (2000)

772 Citations

Drug resistance in Indian visceral leishmaniasis.

Shyam Sundar.
Tropical Medicine & International Health (2001)

748 Citations

Laboratory Diagnosis of Visceral Leishmaniasis

Shyam Sundar;M. Rai.
Clinical and Vaccine Immunology (2002)

741 Citations

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.

T.K. Jha;Shyam Sundar;C.P. Thakur;Peter Bachmann.
The New England Journal of Medicine (1999)

548 Citations

Injectable paromomycin for Visceral leishmaniasis in India.

Shyam Sundar;T K Jha;Chandreshwar P Thakur;Prabhat K Sinha.
The New England Journal of Medicine (2007)

500 Citations

Evidence that the High Incidence of Treatment Failures in Indian Kala-Azar Is Due to the Emergence of Antimony-Resistant Strains of Leishmania donovani

Rosalia Lira;Shyam Sundar;A. Makharia;Richard Kenney.
The Journal of Infectious Diseases (1999)

475 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shyam Sundar

Pradeep Das

Pradeep Das

Micropaleontology Press

Publications: 168

Jean-Claude Dujardin

Jean-Claude Dujardin

Institute of Tropical Medicine Antwerp

Publications: 140

Marleen Boelaert

Marleen Boelaert

Institute of Tropical Medicine Antwerp

Publications: 95

Simon L. Croft

Simon L. Croft

London School of Hygiene & Tropical Medicine

Publications: 76

Marc Ouellette

Marc Ouellette

Université Laval

Publications: 74

Mehdi Mohebali

Mehdi Mohebali

Tehran University of Medical Sciences

Publications: 69

Asrat Hailu

Asrat Hailu

Addis Ababa University

Publications: 62

Mitali Chatterjee

Mitali Chatterjee

Bose (United States)

Publications: 62

Jorge Alvar

Jorge Alvar

Drugs for Neglected Diseases Initiative

Publications: 55

Steven G. Reed

Steven G. Reed

Infectious Disease Research Institute

Publications: 52

Paul M. Kaye

Paul M. Kaye

Hull York Medical School

Publications: 51

Greg Matlashewski

Greg Matlashewski

McGill University

Publications: 48

Petr Volf

Petr Volf

Charles University

Publications: 43

Abhay R. Satoskar

Abhay R. Satoskar

The Ohio State University

Publications: 41

Mary E. Wilson

Mary E. Wilson

University of California, San Francisco

Publications: 40

Ricardo T. Gazzinelli

Ricardo T. Gazzinelli

Universidade Federal de Minas Gerais

Publications: 36

Trending Scientists

Andrew J. Campanella

Andrew J. Campanella

RightHand Robotics, Inc

Uwe R. Kortshagen

Uwe R. Kortshagen

University of Minnesota

Don R. Levitan

Don R. Levitan

Florida State University

Rui-Ming Xu

Rui-Ming Xu

Chinese Academy of Sciences

Kairbaan Hodivala-Dilke

Kairbaan Hodivala-Dilke

Queen Mary University of London

John Maher

John Maher

King's College London

Robert Benezra

Robert Benezra

Memorial Sloan Kettering Cancer Center

Carol A. Erickson

Carol A. Erickson

University of California, Davis

Craig Kletzing

Craig Kletzing

University of Iowa

Christian Seigneur

Christian Seigneur

École des Ponts ParisTech

Scott O. Murray

Scott O. Murray

University of Washington

Christian Gerloff

Christian Gerloff

Universität Hamburg

Udo Dannlowski

Udo Dannlowski

University of Münster

David Rosenthal

David Rosenthal

City University of New York

Marco Perugini

Marco Perugini

University of Milano-Bicocca

R. Michael Rich

R. Michael Rich

University of California, Los Angeles

Something went wrong. Please try again later.